Truist Financial Reiterates “Buy” Rating for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group (NYSE:UNHGet Free Report)‘s stock had its “buy” rating reissued by research analysts at Truist Financial in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $600.00 target price on the healthcare conglomerate’s stock. Truist Financial’s target price points to a potential upside of 21.66% from the stock’s current price.

Other equities analysts also recently issued reports about the company. Wells Fargo & Company lowered their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Barclays initiated coverage on UnitedHealth Group in a research report on Wednesday, March 6th. They issued an “overweight” rating and a $551.00 price objective on the stock. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a research report on Thursday, April 4th. Oppenheimer reiterated an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $596.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 29th. Four research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $569.68.

Get Our Latest Stock Analysis on UNH

UnitedHealth Group Price Performance

NYSE UNH opened at $493.16 on Wednesday. The company has a market capitalization of $454.66 billion, a PE ratio of 30.14, a price-to-earnings-growth ratio of 1.28 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The business’s fifty day moving average is $488.97 and its 200 day moving average is $515.22. UnitedHealth Group has a fifty-two week low of $436.38 and a fifty-two week high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the previous year, the business earned $6.26 earnings per share. Sell-side analysts predict that UnitedHealth Group will post 27.75 earnings per share for the current year.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On UnitedHealth Group

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Kraft Davis & Associates LLC grew its stake in shares of UnitedHealth Group by 3.4% during the 3rd quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock worth $294,000 after purchasing an additional 19 shares during the period. Iron Horse Wealth Management LLC grew its stake in shares of UnitedHealth Group by 1.6% during the 3rd quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock worth $614,000 after purchasing an additional 19 shares during the period. Secure Asset Management LLC grew its stake in shares of UnitedHealth Group by 0.8% during the 3rd quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after purchasing an additional 19 shares during the period. Bensler LLC lifted its position in shares of UnitedHealth Group by 0.3% during the 3rd quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock valued at $3,677,000 after buying an additional 19 shares in the last quarter. Finally, Texas Capital Bancshares Inc TX lifted its position in shares of UnitedHealth Group by 1.1% during the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after buying an additional 19 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.